Emerging evidence has suggested that UBE2C was highly expressed in various tumors and acted as an oncogene, including ovarian cancer, non-small-cell lung cancer, cervical cancer, head and neck squamous cell carcinoma, etc. [12,13,14,15]. This evidence concerns the gene UBE2C and ovarian cancer.